Literature DB >> 25985394

Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.

Bruno Costa-Silva1, Nicole M Aiello2, Allyson J Ocean3, Swarnima Singh1, Haiying Zhang1, Basant Kumar Thakur4, Annette Becker1, Ayuko Hoshino1, Milica Tešić Mark5, Henrik Molina5, Jenny Xiang6, Tuo Zhang6, Till-Martin Theilen1, Guillermo García-Santos1, Caitlin Williams1, Yonathan Ararso1, Yujie Huang1, Gonçalo Rodrigues7, Tang-Long Shen8, Knut Jørgen Labori9, Inger Marie Bowitz Lothe10, Elin H Kure11, Jonathan Hernandez12, Alexandre Doussot12, Saya H Ebbesen1, Paul M Grandgenett13, Michael A Hollingsworth13, Maneesh Jain14, Kavita Mallya14, Surinder K Batra14, William R Jarnagin12, Robert E Schwartz15, Irina Matei1, Héctor Peinado16, Ben Z Stanger2, Jacqueline Bromberg17, David Lyden18.   

Abstract

Pancreatic ductal adenocarcinomas (PDACs) are highly metastatic with poor prognosis, mainly due to delayed detection. We hypothesized that intercellular communication is critical for metastatic progression. Here, we show that PDAC-derived exosomes induce liver pre-metastatic niche formation in naive mice and consequently increase liver metastatic burden. Uptake of PDAC-derived exosomes by Kupffer cells caused transforming growth factor β secretion and upregulation of fibronectin production by hepatic stellate cells. This fibrotic microenvironment enhanced recruitment of bone marrow-derived macrophages. We found that macrophage migration inhibitory factor (MIF) was highly expressed in PDAC-derived exosomes, and its blockade prevented liver pre-metastatic niche formation and metastasis. Compared with patients whose pancreatic tumours did not progress, MIF was markedly higher in exosomes from stage I PDAC patients who later developed liver metastasis. These findings suggest that exosomal MIF primes the liver for metastasis and may be a prognostic marker for the development of PDAC liver metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25985394      PMCID: PMC5769922          DOI: 10.1038/ncb3169

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  67 in total

Review 1.  The extracellular matrix: an active or passive player in fibrosis?

Authors:  Thomas N Wight; Susan Potter-Perigo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-21       Impact factor: 4.052

2.  EGFR isoforms in exosomes as a novel method for biomarker discovery in pancreatic cancer.

Authors:  W Tristram Arscott; Kevin A Camphausen
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

3.  Inhibition of hepatic metastasis in mice treated with cell-binding domain of human fibronectin and angiogenesis inhibitor TNP-470.

Authors:  N Saito; M Mitsuhashi; T Hayashi; C Narumo; H Nagata; K Soyama; S Kameoka; S Harumiya; D Fujimoto
Journal:  Int J Clin Oncol       Date:  2001-10       Impact factor: 3.402

4.  TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression.

Authors:  Aram F Hezel; Vikram Deshpande; Stephanie M Zimmerman; Gianmarco Contino; Brinda Alagesan; Michael R O'Dell; Lee B Rivera; Jay Harper; Scott Lonning; Rolf A Brekken; Nabeel Bardeesy
Journal:  Cancer Res       Date:  2012-07-11       Impact factor: 12.701

Review 5.  Roles of TGF-beta in hepatic fibrosis.

Authors:  Axel M Gressner; Ralf Weiskirchen; Katja Breitkopf; Steven Dooley
Journal:  Front Biosci       Date:  2002-04-01

6.  Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.

Authors:  T H Corbett; B J Roberts; W R Leopold; J C Peckham; L J Wilkoff; D P Griswold; F M Schabel
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

7.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

8.  Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer.

Authors:  Jonathan Ellermeier; Jiwu Wei; Peter Duewell; Sabine Hoves; Mareike R Stieg; Tina Adunka; Daniel Noerenberg; Hans-Joachim Anders; Doris Mayr; Hendrik Poeck; Gunther Hartmann; Stefan Endres; Max Schnurr
Journal:  Cancer Res       Date:  2013-01-21       Impact factor: 12.701

9.  Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-β.

Authors:  Nina Kawelke; Matthaeus Vasel; Carla Sens; Anja von Au; Steven Dooley; Inaam A Nakchbandi
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

10.  Biological Significance of Local TGF-β Activation in Liver Diseases.

Authors:  Hiromitsu Hayashi; Takao Sakai
Journal:  Front Physiol       Date:  2012-02-06       Impact factor: 4.566

View more
  895 in total

1.  Cancer: Organ-seeking vesicles.

Authors:  Janusz Rak
Journal:  Nature       Date:  2015-10-28       Impact factor: 49.962

2.  Organotropic metastasis: role of tumor exosomes.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Res       Date:  2015-12-25       Impact factor: 25.617

3.  Exosomal TGF-β1 is correlated with lymphatic metastasis of gastric cancers.

Authors:  Er-Yen Yen; Shi-Chuen Miaw; Jhang-Sian Yu; I-Rue Lai
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

4.  An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles.

Authors:  Angelica Ortiz; Jun Gui; Farima Zahedi; Pengfei Yu; Christina Cho; Sabyasachi Bhattacharya; Christopher J Carbone; Qiujing Yu; Kanstantsin V Katlinski; Yuliya V Katlinskaya; Simran Handa; Victor Haas; Susan W Volk; Angela K Brice; Kim Wals; Nicholas J Matheson; Robin Antrobus; Sonja Ludwig; Theresa L Whiteside; Cindy Sander; Ahmad A Tarhini; John M Kirkwood; Paul J Lehner; Wei Guo; Hallgeir Rui; Andy J Minn; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  Cancer Cell       Date:  2019-01-14       Impact factor: 31.743

Review 5.  Exosomes: Definition, Role in Tumor Development and Clinical Implications.

Authors:  Alberto Carretero-González; Irene Otero; Lucía Carril-Ajuria; Guillermo de Velasco; Luis Manso
Journal:  Cancer Microenviron       Date:  2018-05-03

6.  Decoding the Role of Extracellular Vesicles in Liver Diseases.

Authors:  Fengyan Deng; Nancy Magee; Yuxia Zhang
Journal:  Liver Res       Date:  2017-12-07

Review 7.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

Review 8.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.

Authors:  Amber L Simpson; Alexandre Doussot; John M Creasy; Lauryn B Adams; Peter J Allen; Ronald P DeMatteo; Mithat Gönen; Nancy E Kemeny; T Peter Kingham; Jinru Shia; William R Jarnagin; Richard K G Do; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2017-05-30       Impact factor: 5.344

Review 10.  Tumor exosomes: a double-edged sword in cancer therapy.

Authors:  Wei Sun; Ju-Dong Luo; Hua Jiang; Dayue Darrel Duan
Journal:  Acta Pharmacol Sin       Date:  2018-03-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.